RPL29
Large ribosomal subunit protein eL29
Also known as: HIP, HUMRPL29, L29, RL29_HUMAN, RPL29P10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P47914
- Gene
- RPL29
- Ensembl
- ENSG00000162244
- Chromosome
- 3
- Canonical length
- 159 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Nucleoli,Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L29E family of ribosomal proteins. The protein is also a peripheral membrane protein expressed on the cell surface that directly binds heparin. Although this gene was previously reported to map to 3q29-qter, it is believed that it is located at 3p21.3-p21.2. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
159 residues, UniProt reviewed canonical sequence.
>P47914|RPL29
1 MAKSKNHTTH NQSRKWHRNG IKKPRSQRYE SLKGVDPKFL RNMRFAKKHN KKGLKKMQAN
61 NAKAMSARAE AIKALVKPKE VKPKIPKGVS RKLDRLAYIA HPKLGKRARA RIAKGLRLCR
121 PKAKAKAKAK DQTKAQAAAP ASVPAQAPKR TQAPTKASELocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL29 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 2,732 nTPM
Expression across tissuesHPA
Tissue
- ovary: 2,732 nTPM
- pancreas: 2,637 nTPM
- skeletal muscle: 2,630 nTPM
- skin: 2,404 nTPM
- bone marrow: 1,989 nTPM
- cervix: 1,746 nTPM
Single-cell type
- esophageal suprabasal cells: 9,427 nCPM
- esophageal basal cells: 8,164 nCPM
- decidual stromal cells: 7,729 nCPM
- pancreatic acinar cells: 7,439 nCPM
- esophageal apical cells: 6,931 nCPM
- late spermatids: 6,589 nCPM
Immune cell
- total PBMC: 3,515 nTPM
- memory B-cell: 1,895 nTPM
- naive B-cell: 1,758 nTPM
- naive CD4 T-cell: 1,668 nTPM
- MAIT T-cell: 1,492 nTPM
- memory CD4 T-cell: 1,451 nTPM
Brain region
- white matter: 450 nTPM
- spinal cord: 440 nTPM
- medulla oblongata: 392 nTPM
- thalamus: 363 nTPM
- basal ganglia: 350 nTPM
- pons: 338 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0.2
- gnomAD missense Z
- 0.36
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Large ribosomal subunit protein eL29
- Ribosomal L29e protein family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPL29 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL29 as an antibody target. Whether an autoantibody or antibody against RPL29 could matter depends on whether native RPL29 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL29 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL29 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...